GERD:XETRA:XETRA-L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating EUR (EUR)

ETF | Others |

Last Closing

USD 12.222

Change

0.00 (-0.03)%

Market Cap

USD 0.45B

Volume

0.15M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.23 (+0.44%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.06 (+0.34%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.17 (+0.60%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.10 (+0.35%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.05 (+0.18%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.04%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

-0.50 (-0.35%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.20 (+0.39%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.14 (+0.13%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.36 (+0.06%)

USD 80.38B

ETFs Containing GERD:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.96% 72% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.96% 72% C 68% D+
Trailing 12 Months  
Capital Gain 21.71% 74% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.71% 73% C 73% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.06% 52% F 53% F
Dividend Return 7.06% 51% F 51% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.02% 63% D 70% C-
Risk Adjusted Return 70.40% 61% D- 66% D+
Market Capitalization 0.45B 63% D 56% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike